Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 9, 2008
Bugs versus drugs: addressing the pharmacist's challengeDavid S Burgess, Robert P RappPostgraduate Medicine|August 12, 2009
Clinical and economic outcomes in respiratory tract infections: The impact of bacterial resistanceRobert P RappPharmacotherapy|March 3, 2004
Changing strategies for the management of invasive fungal infectionsRobert P RappPharmacotherapy|April 11, 2012
Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concernsRobert P Rapp, Carl UrbanOrthopedics|November 22, 2005
Why is the microbiology lab calling about an extended-spectrum beta-lactamase bacterium from a wound culture?Julie Ribes, Robert P RappClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2005
Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infectionsDavid S BurgessJournal of Managed Care Pharmacy : JMCP|June 10, 2009
Curbing resistance development: maximizing the utility of available agentsDavid S BurgessOrthopedics|July 9, 2004
Methicillin-resistant staphylococcal infections: an important consideration for orthopedic surgeonsWael E Shams, Robert P RappPathogens and Disease|August 1, 2019
Imipenem/relebactam activity compared to other antimicrobials against non-MBL-producing carbapenem-resistant Enterobacteriaceae from an academic medical centerBrandon Kulengowski, David S BurgessDiagnostic Microbiology and Infectious Disease|October 12, 2002
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosaDavid S Burgess, Surakit NathisuwanPageof 10